Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib Prior to Radical Prostatectomy in Locally Advanced Prostate Cancer
NCT03432897Phase 2Terminated
- Sponsor
- Brown University
- Start
- May 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in prostate cancer (PCa), sponsored by Brown University. Started May 2018; status: terminated.
02
Drugs
olaparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03432897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432897.